Proteinuria: all 328 studies
Page 4 of 4. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes MellitusCompletedNCT00419835Phase 4
- Correlation of Urinary Kallikrein With Cytokines, Proteinuria and Renal Function in Chronic Renal Disease PatientsCompletedNCT00395005
- Impact of Screening Patients With HIV for Kidney DiseaseWithdrawnNCT00392132
- Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and ProteinuriaSuspendedNCT00369538Phase 4
- TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )TerminatedNCT00368264Phase 2/3
- Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA NephropathyCompletedNCT00367562Phase 4
- Pioglitazone and Losartan Provides Additional RenoprotectionCompletedNCT00364988Not applicable
- Olmesartan Medoxomil and Diabetic NephropathyCompletedNCT00362960Phase 3
- Delaying the Progression of Diabetic Nephropathy in Pima IndiansCompletedNCT00353600
- Antiproteinuric Agents and Fabry DiseaseCompletedNCT00343577
- Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal InsufficiencyTerminatedNCT00338091Not applicable
- Calcitriol in the Treatment of Immunoglobulin A (IgA) NephropathyCompletedNCT00319761Phase 4
- Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk PatientsCompletedNCT00285298Phase 3
- Kidney Disease BiomarkersCompletedNCT00255398
- The Effects of Obesity and Protein Intake on the KidneyCompletedNCT00244790Not applicable
- High Doses of Candesartan Cilexetil on the Reduction of ProteinuriaCompletedNCT00242346Phase 3
- Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes MellitusCompletedNCT00241085Phase 4
- Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)CompletedNCT00234871Phase 4
- High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB TherapyCompletedNCT00212901Not applicable
- Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.TerminatedNCT00200694Phase 4
- Statins in Proteinuric NephropathiesCompletedNCT00199927Phase 3
- Treatment Targets for Chronic Hypertension in PregnancyWithdrawnNCT00194974Phase 1/2
- Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled HypertensionCompletedNCT00160225Phase 2
- Effect of Sulodexide in Overt Diabetic NephropathyTerminatedNCT00130312Phase 4
- Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the KidneyCompletedNCT00106561Phase 2/3
- Sirolimus for Focal Segmental GlomerulosclerosisCompletedNCT00040508Phase 2
- Once-A-Month Steroid Treatment for Patients With Focal Segmental GlomerulosclerosisCompletedNCT00004990Phase 2
- Determination of Kidney FunctionTerminatedNCT00001978